Robert Kerwin

Overview

Best Publications

• Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

  Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

  1736
  Citations

• Functional Connectivity and Brain Networks in Schizophrenia

  Mary-Ellen Lynall;Danielle S. Bassett;Danielle S. Bassett;Robert Kerwin;Peter J. McKenna

  1594
  Citations

• The Maudsley Prescribing Guidelines

  David Taylor;Carol Paton;Robert Kerwin

  786
  Citations

• Pharmacogenetic prediction of clozapine response.

  M J Arranz;J Munro;J Birkett;A Bolonna

  483
  Citations

• Association between clozapine response and allelic variation in 5-HT2A receptor gene

  Maria Arranz;David Collier;Monsheel S. Sodhi;David Ball

  449
  Citations

• The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity.

  Michael J. Parsons;Ursula M. D'Souza;Maria-Jesus Arranz;Robert W. Kerwin

  359
  Citations

• Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET

  N.S. Gray;L.S. Pilowsky;J.A. Gray;R.W. Kerwin

  358
  Citations

• Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.

  Jennifer Court;Dean Spurden;Stephen Lloyd;Ian McKeith

  356
  Citations

• Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response

  M. J. Arranz;J. Munro;P. Sham;George Kirov

  355
  Citations

• Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

  Janet Munro;Desmond O'Sullivan;Christopher Andrews;Alejandro Arana

  349
  Citations

• Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

  Sarah Lewis;L Davies;Pamela Jones;T R E Barnes

  331
  Citations

• Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

  P.J Harrison;D McLaughlin;R.W Kerwin

  330
  Citations

• Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine

  M. J. Arranz;J. Munro;Michael John Owen;G. Spurlock

  309
  Citations

• Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.

  Sharon L. Eastwood;Brendan McDonald;Philip W.J. Burnet;Jason P. Beckwith

  295
  Citations

• Do antidepressants regulate how cortisol affects the brain

  Carmine M. Pariante;Sarah A. Thomas;Simon Lovestone;Andrew Makoff

  274
  Citations

• CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS

  J.G. Clarke;R. Kerwin;S. Larkin;Y. Lee

  268
  Citations

• Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.

  L.S. Pilowsky;R.M. Murray;R.W. Kerwin;D.C. Costa

  260
  Citations

• Association between clozapine response and allelic variation in the 5-HT2C receptor gene.

  Monsheel S. Sodhi;Maria J. Arranz;David Curtis;David M. Ball

  258
  Citations

• Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality.

  David Cotter;Robert Kerwin;Safa Al-Sarraji;Jean Pierre Brion

  212
  Citations

• Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study.

  Declan G. M. Murphy;Eileen Daly;Nicole Schmitz;Fiona Toal

  211
  Citations